Mechanisms of Weight Loss With SGLT2 Inhibition

Clinical trial NCT02360774 · COMPLETED

Trial details

NCT number: NCT02360774
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Overweight Obesity

Start date: 2015-02-01
Primary completion: 2018-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.